-
公开(公告)号:US20070010660A1
公开(公告)日:2007-01-11
申请号:US11463863
申请日:2006-08-10
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
IPC分类号: A61K38/19 , C07K14/535
摘要: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.
摘要翻译: 具有G-CSF活性的多肽缀合物包含与人G-CSF序列相比具有至少一个引入的赖氨酸残基和至少一个去除的赖氨酸残基的多肽,并与2-6个聚乙二醇部分缀合。 缀合物具有低的体外生物活性,长的体内半衰期,减少的受体介导的清除,并且提供比非共轭重组人G-CSF更快速地刺激白细胞和嗜中性粒细胞的产生。
-
公开(公告)号:US20070004904A1
公开(公告)日:2007-01-04
申请号:US11462354
申请日:2006-08-03
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
IPC分类号: A61K31/70 , C07K14/00 , A01N43/04 , C07K16/00 , A61K38/00 , C07K17/00 , C07K2/00 , C07K4/00 , C07K5/00 , C07K7/00
CPC分类号: C07K14/535 , A61K9/0019 , A61K38/00 , A61K47/42 , A61K47/60 , A61K47/61 , C07K14/53
摘要: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.
-
公开(公告)号:US20060286069A1
公开(公告)日:2006-12-21
申请号:US11463867
申请日:2006-08-10
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
摘要: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.
摘要翻译: 具有G-CSF活性的多肽缀合物包含与人G-CSF序列相比具有至少一个引入的赖氨酸残基和至少一个去除的赖氨酸残基的多肽,并与2-6个聚乙二醇部分缀合。 缀合物具有低的体外生物活性,长的体内半衰期,减少的受体介导的清除,并且提供比非共轭重组人G-CSF更快速地刺激白细胞和嗜中性粒细胞的产生。
-
公开(公告)号:US20050095684A1
公开(公告)日:2005-05-05
申请号:US11004461
申请日:2004-12-03
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
CPC分类号: C07K14/535 , A61K9/0019 , A61K38/00 , A61K47/42 , C07K14/53
摘要: Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a low in vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugated recombinant human G-CSF.
摘要翻译: 具有G-CSF活性的多肽缀合物包含与人G-CSF序列相比具有至少一个引入的赖氨酸残基和至少一个去除的赖氨酸残基的多肽,并与2-6个聚乙二醇部分缀合。 缀合物具有低的体外生物活性,长的体内半衰期,减少的受体介导的清除,并且提供比非共轭重组人G-CSF更快速地刺激白细胞和嗜中性粒细胞的产生。
-
公开(公告)号:US4491195A
公开(公告)日:1985-01-01
申请号:US451217
申请日:1982-11-09
申请人: Jan Mikkelsen , Kjell Sorlie
发明人: Jan Mikkelsen , Kjell Sorlie
CPC分类号: B66F9/08
摘要: The invention relates to an adjustable mounting arrangement (10) for a rotatable guide member (12) of a lift mast assembly (14) which eliminates the problems of inadvertent loosening, complexity of adjustment and premature wear. The mounting arrangement (10) includes a shaft (36) having an eccentric portion (42) upon which the rotatable guide member (12) is mounted. A cam member (78) is connected to a first end portion (38) of the shaft (36) and engageable by a mating member (86) which retains the shaft (36), at one of a plurality of incrementally rotational positions of the cam member (78) from rotational and axial movement. The mounting arrangement (10) is particularly useful in lift chain guide and side thrust roller applications.
摘要翻译: PCT No.PCT / US82 / 01572 Sec。 371日期1982年11月8日 102(e)日期1982年11月8日PCT申请日1982年11月9日PCT公布。 公开号WO84 / 01803 日期:1984年5月10日本发明涉及一种用于提升桅杆组件(14)的可旋转引导构件(12)的可调安装装置(10),其消除了无意松动,调整复杂性和过早磨损的问题。 安装装置(10)包括具有偏心部分(42)的轴(36),可旋转导向构件(12)安装在该偏心部分上。 凸轮构件(78)连接到所述轴(36)的第一端部(38),并且可通过将所述轴(36)保持在所述轴(36)的多个递增旋转位置中的一个上的配合构件(86) 凸轮构件(78)从旋转和轴向移动。 安装装置(10)特别适用于升降链导向装置和侧向推力滚筒应用。
-
公开(公告)号:US20060270703A1
公开(公告)日:2006-11-30
申请号:US11462353
申请日:2006-08-03
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
CPC分类号: C07K14/535 , A61K9/0019 , A61K38/00 , A61K47/42 , A61K47/60 , A61K47/61 , C07K14/53
摘要: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.
-
公开(公告)号:US20060084793A1
公开(公告)日:2006-04-20
申请号:US11196846
申请日:2005-08-03
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
IPC分类号: C07K14/54
CPC分类号: A61K9/0019 , A61K38/00 , A61K47/42 , C07K14/535
摘要: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g., be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g., be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate has one or more improved properties such as increased biological half-life and reduced side effects.
-
公开(公告)号:US4995469A
公开(公告)日:1991-02-26
申请号:US412048
申请日:1989-09-25
申请人: Jan Mikkelsen , Kjell Sorlie
发明人: Jan Mikkelsen , Kjell Sorlie
IPC分类号: B62D1/22 , B62D33/063 , B66F9/075
CPC分类号: B62D1/22 , B62D33/063 , B66F9/07545
摘要: A mounting arrangement which facilitates the positioning of an operator's station on the frame of a work vehicle at a plurality of elevationally spaced apart positions relative to a longitudinal axis of the work vehicle and permits control of the operation of the work vehicle from each of the first and second positions is provided. The mounting arrangement includes first and second elevationally spaced apart frames for supporting the operator's station at the first and second spaced apart locations, respectively. A connecting device connects the operator's station to the first and second frames. A controllable component which is mounted on the vehicle frame is adapted to vary operation of a function of the vehicle. The controllable component is connected to a selecting device mounted on the operator's station by a directing device which passes a control signal from the selecting device to the controllable component. The mounting arrangement is particularly suited for use on a material handling vehicle.
摘要翻译: 一种安装装置,其有助于操作员站在工作车辆的框架上相对于作业车辆的纵向轴线在多个高度间隔开的位置定位,并且允许从第一个工作车辆中的每一个控制工作车辆的操作 并提供第二位置。 安装装置包括分别用于在第一和第二间隔开的位置处支撑操作员站的第一和第二高度间隔开的框架。 连接装置将操作员站连接到第一和第二帧。 安装在车架上的可控部件适于改变车辆功能的操作。 可控部件通过将控制信号从选择装置传递到可控部件的引导装置连接到安装在操作员站上的选择装置。 安装方式特别适用于材料搬运车辆。
-
公开(公告)号:US20070123696A1
公开(公告)日:2007-05-31
申请号:US11462331
申请日:2006-08-03
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
IPC分类号: A61K31/70 , C07K14/00 , A01N43/04 , C07K16/00 , A61K38/00 , C07K17/00 , C07K2/00 , C07K4/00 , C07K5/00 , C07K7/00
CPC分类号: C07K14/535 , A61K9/0019 , A61K38/00 , A61K47/42 , A61K47/60 , A61K47/61 , C07K14/53
摘要: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g. be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate, which has a reduced in vitro bioactivity compared to hG-CSF, has one or more improved properties such as increased biological half-life and increased stimulation of neutrophils.
摘要翻译: 本发明涉及多肽缀合物,其包含显示G-CSF活性的多肽,并且具有不同于至少一个指定的引入和/或去除的氨基酸残基中的人G-CSF的氨基酸序列的氨基酸序列,所述氨基酸残基包含用于 非多肽部分,并且具有连接到多肽的连接基团的至少一个非多肽部分。 附件组可以例如。 是赖氨酸,半胱氨酸,天冬氨酸或谷氨酸残基或糖基化位点,并且非多肽部分可以是例如。 作为聚合物如聚乙二醇或寡糖。 与hG-CSF相比,具有降低的体外生物活性的缀合物具有一种或多种改进的性质,例如增加的生物半衰期和增加的嗜中性粒细胞的刺激。
-
公开(公告)号:US20060275257A1
公开(公告)日:2006-12-07
申请号:US11462037
申请日:2006-08-02
申请人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
发明人: Torben Nissen , Kim Andersen , Christian Hansen , Jan Mikkelsen , Hans Schambye
CPC分类号: A61K9/0019 , A61K38/00 , A61K47/42 , C07K14/535
摘要: The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acid sequence of human G-CSF in at least one specified introduced and/or removed amino acid residue comprising an attachment group for a non-polypeptide moiety, and having at least one non-polypeptide moiety attached to an attachment group of the polypeptide. The attachment group may e.g., be a lysine, cysteine, aspartic acid or glutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g., be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate has one or more improved properties such as increased biological half-life and reduced side effects.
摘要翻译: 本发明涉及多肽缀合物,其包含显示G-CSF活性的多肽,并且具有不同于至少一个指定的引入和/或去除的氨基酸残基中的人G-CSF的氨基酸序列的氨基酸序列,所述氨基酸残基包含用于 非多肽部分,并且具有连接到多肽的连接基团的至少一个非多肽部分。 连接基团可以例如是赖氨酸,半胱氨酸,天冬氨酸或谷氨酸残基或糖基化位点,并且非多肽部分可以例如是聚合物,例如聚乙二醇或低聚糖。 缀合物具有一个或多个改进的性质,例如增加的生物半衰期和减少的副作用。
-
-
-
-
-
-
-
-
-